Comparing Pain Relief Between Two Methods of Freezing Injections in Children Having Their Appendix Removed
Launched by UNIVERSITY OF BRITISH COLUMBIA · Apr 22, 2025
Trial Information
Current as of July 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This clinical trial is studying how to help children feel less pain after having their appendix removed through a surgery called laparoscopic appendectomy. The researchers want to compare two different methods of pain relief: one method uses a special freezing injection along with a medicine called dexamethasone, while the other method uses just the freezing injection. The goal is to find out which method helps kids recover more comfortably and quickly after their surgery.
To be part of this trial, children must be between 4 and 18 years old and have been diagnosed with acute appendicitis, which is when the appendix becomes inflamed and needs to be removed. However, children with certain conditions, like previous abdominal surgeries or allergies to specific medications, won't be eligible. Participants can expect to receive one of the two treatment methods before their surgery and will be monitored for their pain levels and recovery progress afterward. This study is important because it aims to reduce the need for strong pain medications and improve the overall recovery experience for young patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 4-18 years old
- • Diagnosed with acute appendicitis.
- • Undergoing a laparoscopic appendectomy
- Exclusion Criteria:
- • Perforated/complicated appendicitis diagnosis
- • Previous abdominal surgery
- • Allergy to bupivacaine or dexamethasone
- • Severe developmental delay preventing patients from using pain scales or adequately communicating pain
- • Patients with Type 1 or 2 diabetes mellitus
- • Patients with steroid dependence
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Prakash Krishnan, MD
Principal Investigator
University of British Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported